TCS’ Connected Clinical Trials Platform Wins the European Innovations Award

Tata Consultancy Services (TCS) announced that its Connected Clinical Trials (CCT) platform has won the 2019 European Innovations Award at the Summit for Clinical Operations Executives (SCOPE) – Europe.

Clinical Research News’ European Innovations Awards recognize outstanding examples of applied strategic innovation - partnerships, deployments, and collaborations that manifestly improve the clinical trial process. CCT was recognized for its thoughtful approach to solving tough industry problems, its ability to provide quantifiable returns on investment and ease of deployment.

“TCS is focused on harnessing the power of digital technologies to transform the drug development value chain in the life sciences industry, creating innovative solutions that deliver greater value for our customers and superior patient outcomes,” said Debashis Ghosh, Global Head, Life Sciences and Healthcare, TCS. “Our CCT platform encompasses the complete clinical trials ecosystem and helps sponsors achieve enhanced patient engagement, ensure better adherence to test protocols, and achieve greater transparency, efficiency, and compliance with regulatory guidelines.”

“These awards celebrate dedication and innovation in clinical research, and the winners chosen highlight the inspiring work being done in the industry. The research community in Europe is increasingly open, and the projects showcased in this year's award program prove their dedication to excellence," said Allison Proffitt, Editorial Director, Clinical Research News. "We were particularly pleased with this year’s entries. The winners represented some of the best innovation in clinical research, and the judges and I were thrilled with the caliber of solutions from Tata Consultancy Services."

An innovative Software-as-a-Service (SaaS) platform, CCT connects patients, sites, and sponsors and leverages sensors, smart packages, and mobile devices and apps to enable real-time data integration, analytics and tailored patient support. It provides end-to-end visibility on how clinical supplies are managed, both on site and at the patients’ homes, and significantly transforms patient engagement in clinical trials.

CCT is part of TCS’ Advanced Drug Development (ADD) suite that leverages the power of Artificial Intelligence by offering a wide range of cloud-based clinical solutions and services in the areas of clinical data management, metadata management, pharmacovigilance, and data analytics and insights.